These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 21728901)

  • 1. Methylation status of the gene promoter of cyclin-dependent kinase inhibitor 2A (CDKN2A) in ovarian cancer.
    Abou-Zeid AA; Azzam AZ; Kamel NA
    Scand J Clin Lab Invest; 2011 Nov; 71(7):542-7. PubMed ID: 21728901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promoter hypermethylation profile of ovarian epithelial neoplasms.
    Makarla PB; Saboorian MH; Ashfaq R; Toyooka KO; Toyooka S; Minna JD; Gazdar AF; Schorge JO
    Clin Cancer Res; 2005 Aug; 11(15):5365-9. PubMed ID: 16061849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Gene methylation in stool for the screening of colorectal cancer and pre-malignant lesions].
    Kang YP; Cao FA; Chang WJ; Lou Z; Wang H; Wu LL; Fu CG; Cao GW
    Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Jan; 14(1):52-6. PubMed ID: 21271382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The high frequency of de novo promoter methylation in synchronous primary endometrial and ovarian carcinomas.
    Furlan D; Carnevali I; Marcomini B; Cerutti R; Dainese E; Capella C; Riva C
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3329-36. PubMed ID: 16740754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GnRH-II mRNA expression in tumor tissue and peripheral blood mononuclear cells (PBMCs) in patients with malignant and benign ovarian tumors.
    Serin IS; Tanriverdi F; Ata CD; Akalin H; Ozcelik B; Ozkul Y; Kelestimur F
    Eur J Obstet Gynecol Reprod Biol; 2010 Mar; 149(1):92-6. PubMed ID: 20018426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic inactivation of BRCA1 through promoter hypermethylation in ovarian cancer progression.
    Wang YQ; Yan Q; Zhang JR; Li SD; Yang YX; Wan XP
    J Obstet Gynaecol Res; 2013 Feb; 39(2):549-54. PubMed ID: 23006047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CDKN2A promoter methylation in gastric adenocarcinomas: clinical variables.
    Vo QN; Geradts J; Boudreau DA; Bravo JC; Schneider BG
    Hum Pathol; 2002 Dec; 33(12):1200-4. PubMed ID: 12514789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased expression of RIZ1 and its clinicopathological significance in epithelial ovarian carcinoma: correlation with epigenetic inactivation by aberrant DNA methylation.
    Akahira J; Suzuki F; Suzuki T; Miura I; Kamogawa N; Miki Y; Ito K; Yaegashi N; Sasano H
    Pathol Int; 2007 Nov; 57(11):725-33. PubMed ID: 17922684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid-binding protein/cell adhesion molecule-like (OPCML) gene and promoter methylation status in women with ovarian cancer.
    Czekierdowski A; Czekierdowska S; Szymanski M; Wielgos M; Kaminski P; Kotarski J
    Neuro Endocrinol Lett; 2006 Oct; 27(5):609-13. PubMed ID: 17159813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene promoter hypermethylation in tumors and lymph nodes of stage I lung cancer patients.
    Harden SV; Tokumaru Y; Westra WH; Goodman S; Ahrendt SA; Yang SC; Sidransky D
    Clin Cancer Res; 2003 Apr; 9(4):1370-5. PubMed ID: 12684406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Several mechanisms lead to the inactivation of the CDKN2A (P16), P14ARF, or CDKN2B (P15) genes in the GCB and ABC molecular DLBCL subtypes.
    Guney S; Jardin F; Bertrand P; Mareschal S; Parmentier F; Picquenot JM; Tilly H; Bastard C
    Genes Chromosomes Cancer; 2012 Sep; 51(9):858-67. PubMed ID: 22619049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multiplex methylation-specific PCR assay for the detection of early-stage ovarian cancer using cell-free serum DNA.
    Zhang Q; Hu G; Yang Q; Dong R; Xie X; Ma D; Shen K; Kong B
    Gynecol Oncol; 2013 Jul; 130(1):132-9. PubMed ID: 23623832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The values of serum human epididymis secretory protein 4 and CA(125) assay in the diagnosis of ovarian malignancy].
    Dong L; Chang XH; Ye X; Zhu LR; Zhao Y; Tian L; Cheng HY; Li XP; Zhang H; Liao QP; Fu TY; Cheng YX; Cui H
    Zhonghua Fu Chan Ke Za Zhi; 2008 Dec; 43(12):931-6. PubMed ID: 19134334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p16 overexpression: a potential early indicator of transformation in ovarian carcinoma.
    Shigemasa K; Hu C; West CM; Clarke J; Parham GP; Parmley TH; Korourian S; Baker VV; O'Brien TJ
    J Soc Gynecol Investig; 1997; 4(2):95-102. PubMed ID: 9101469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microvessel density and CpG island methylation of the THBS2 gene in malignant ovarian tumors.
    Czekierdowski A; Czekierdowska S; Danilos J; Czuba B; Sodowski K; Sodowska H; Szymanski M; Kotarski J
    J Physiol Pharmacol; 2008 Sep; 59 Suppl 4():53-65. PubMed ID: 18955754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequent loss of the CDKN2C (p18INK4c) gene product in pituitary adenomas.
    Kirsch M; Mörz M; Pinzer T; Schackert HK; Schackert G
    Genes Chromosomes Cancer; 2009 Feb; 48(2):143-54. PubMed ID: 18973139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CDKN2A gene inactivation in epithelial sporadic ovarian cancer.
    Niederacher D; Yan HY; An HX; Bender HG; Beckmann MW
    Br J Cancer; 1999 Aug; 80(12):1920-6. PubMed ID: 10471040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Inactivation of CDKN2A gene (p16) in gallbladder carcinoma].
    Roa JC; Vo Q; Araya JC; Villaseca M; Guzmán P; Ibacache GS; de Aretxabala X; Roa I
    Rev Med Chil; 2004 Nov; 132(11):1369-76. PubMed ID: 15693199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P16/CDKN2A and Ki-67 enhance the detection of anal intraepithelial neoplasia and condyloma and correlate with human papillomavirus detection by polymerase chain reaction.
    Pirog EC; Quint KD; Yantiss RK
    Am J Surg Pathol; 2010 Oct; 34(10):1449-55. PubMed ID: 20871219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant methylation of the CDKN2a/p16INK4a gene promoter region in preinvasive bronchial lesions: a prospective study in high-risk patients without invasive cancer.
    Lamy A; Sesboüé R; Bourguignon J; Dautréaux B; Métayer J; Frébourg T; Thiberville L
    Int J Cancer; 2002 Jul; 100(2):189-93. PubMed ID: 12115568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.